Video Experimental Relacionado
Updated: Jul 28, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Las políticas gubernamentales y el costo de hacer investigación
Science (New York, N.Y.)
|February 1, 1985
Resumen
El financiamiento federal para la investigación se está desacelerando mientras que la ciencia se vuelve más cara. Esto afecta la investigación universitaria, lo que lleva a un aumento de la financiación de la industria y desafíos a las prácticas científicas tradicionales.
Área de la Ciencia:
- Economía política de las ciencias de la ciencia.
- Investigación Financiación de la investigación
- Investigación Universitaria de Investigación en la Universidad.
Sus antecedentes:
- La ciencia se ha vuelto cada vez más intensiva en capital.
- El apoyo federal a los programas de investigación ha experimentado un crecimiento más lento.
Objetivo del estudio:
- Analizar el impacto de las tendencias económicas cambiantes en la práctica de la ciencia.
- Identificar las consecuencias de un déficit de capital en la investigación universitaria.
Principales métodos:
- Análisis de las tendencias en la financiación científica y la asignación de recursos.
- Examen de la relación entre el apoyo federal, la financiación de la industria y las prácticas institucionales.
Principales resultados:
- Aumento de la dependencia de la financiación de la industria privada para la investigación universitaria.
- Aparición de estrategias para eludir los procesos tradicionales de revisión por pares y asignación.
- Crecientes conflictos entre instituciones e investigadores por la distribución de los recursos.
Conclusiones:
- Los cambios económicos actuales amenazan los métodos establecidos y efectivos de investigación científica.
- Se necesita una atención urgente para abordar la sostenibilidad de la empresa científica.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:20Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:22Bias
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...